| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0019 | 1 |